GlycoMimetics Valuation
| GLYC Stock | USD 0.27 0.01 3.85% |
GlycoMimetics seems to be undervalued based on Macroaxis valuation methodology. Our model calculates the value of GlycoMimetics from evaluating the firm fundamentals such as Return On Asset of -0.72, shares owned by insiders of 2.86 %, and Return On Equity of -1.73 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that GlycoMimetics' price fluctuation is out of control at this time. Calculation of the real value of GlycoMimetics is based on 3 months time horizon. Increasing GlycoMimetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GlycoMimetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GlycoMimetics Stock. However, GlycoMimetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.27 | Real 0.45 | Hype 0.28 | Naive 0.29 |
The real value of GlycoMimetics Stock, also known as its intrinsic value, is the underlying worth of GlycoMimetics Company, which is reflected in its stock price. It is based on GlycoMimetics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GlycoMimetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GlycoMimetics helps investors to forecast how GlycoMimetics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GlycoMimetics more accurately as focusing exclusively on GlycoMimetics' fundamentals will not take into account other important factors: GlycoMimetics Total Value Analysis
GlycoMimetics is currently anticipated to have valuation of 6.61 M with market capitalization of 17.37 M, debt of 66.84 M, and cash on hands of 60.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GlycoMimetics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.61 M | 17.37 M | 66.84 M | 60.24 M |
GlycoMimetics Asset Utilization
One of the ways to look at asset utilization of GlycoMimetics is to check how much profit was generated for every dollar of assets it reports. GlycoMimetics retains a negative application of resources of -0.72 (percent), losing $0.007204 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of GlycoMimetics shows how discouraging it operates for each dollar spent on its resources.GlycoMimetics Ownership Allocation
GlycoMimetics has a total of 64.51 Million outstanding shares. 30% of GlycoMimetics outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.GlycoMimetics Profitability Analysis
Net Loss for the year was (37.88 B) with profit before overhead, payroll, taxes, and interest of 10 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GlycoMimetics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GlycoMimetics and how it compares across the competition.
About GlycoMimetics Valuation
The stock valuation mechanism determines GlycoMimetics' current worth on a weekly basis. Our valuation model uses a comparative analysis of GlycoMimetics. We calculate exposure to GlycoMimetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GlycoMimetics's related companies.GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
GlycoMimetics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 64.5 M |
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |